Time-resolved
monitoring of the permeability of analytes is of
utmost importance in membrane research. Existing methods are restricted
to single-point determinations or flat synthetic membranes, limiting
access to biologically relevant kinetic parameters (permeation rate
constant, permeation coefficients). We now use the recently introduced
fluorescent artificial receptor membrane assay (FARMA) as a method
to monitor, in real time, the permeation of indole derivatives through
liposomal membranes of different lipid compositions. This method is
based on the liposomal encapsulation of a chemosensing ensemble or
“fluorescent artificial receptor”, consisting of 2,7-dimethyldiazapyrenium
as a fluorescent dye and cucurbit[8]uril as the macrocyclic receptor,
that responds to the complexation of a permeating aromatic analyte
by fluorescence quenching. FARMA does not require a fluorescent labeling
of the analytes and allows access to permeability coefficients in
the range from 10–8 to 10–4 cm
s–1. The effect of temperature on the permeation
rate of a series of indole derivatives across the phospholipid membranes
was studied. The activation energies for permeation through POPC/POPS
phospholipid membranes were in the range of 28–96 kJ mol–1. To study the effect of different lipid phases on
the membrane permeability, we performed experiments with DPPC/DOPS
vesicles, which showed a phase transition from a gel phase to a liquid-crystalline
phase, where the activation energies for the permeation process were
expected to show a dramatic change. Accordingly, for the permeation
of the indole derivatives into the DPPC/DOPS liposomes, discontinuities
were observed in the Arrhenius plots, from which the permeation activation
energies for the distinct phases could be determined, for example,
for tryptamine 245 kJ mol–1 in the gel phase and
47 kJ mol–1 in the liquid-crystalline phase.